New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial markets, today, celebrates the grand opening of its dedicated Health & Pharma Solutions Innovation Center in São Paulo, Brazil.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016102423/en/
Credits to Roquette
Located in Barueri, near São Paulo’s city center, the state-of-the-art facility represents a multi-million-dollar investment and reinforces Roquette’s commitment as the pharmaceutical industry’s go-to partner for the development of drug delivery solutions that contribute to life-saving therapies. The center will enable scientific experts to leverage advanced tools, technologies, and expertise to deliver tailored solutions to customers.
“Roquette’s new Pharmaceutical Innovation Center in São Paulo marks a significant milestone in our commitment to global innovation and partnership,” said Isabelle Bouvier, CEO of Roquette’s Health & Pharma Solutions. “This leading-edge facility will foster collaboration with our customers among brilliant minds while creating new opportunities for our employees and the broader community.”
Serving as a regional hub, the center supports customers throughout the entire product development journey – from initial concept to market launch. Roquette’s proven expertise in polymers and formulation, combined with trusted brands like Avicel® microcrystalline cellulose, METHOCEL™ hydroxypropyl methylcellulose, MICROCEL® microcrystalline cellulose, and PEARLITOL® mannitol, will help to accelerate development timelines, minimize waste, and reduce manufacturing costs.
“Latin America is a dynamic market with immense potential,” said Adriana Quiroga, Application, Development & Innovation Leader, Latin America, for the Health & Pharma Solutions Business Group. “We’re accelerating our product development and our time-to-market, as well as delivering innovative solutions that have a global impact.”
Roquette Health & Pharma Solutions is partnering with the Northeast Center for Strategic Technologies to empower young women to pursue careers in science, technology, engineering and mathematics through the Futuras Cientistas program. Roquette’s scientists will mentor the program’s youth and invite them to shadow them at the new laboratory.
"At CETENE, we believe that true progress begins with inclusion," said Dr. Giovanna Machado, Senior Researcher at the Center for Strategic Technologies of the Northeast. "Through Futuras Cientistas, and in partnership with Roquette, we are opening doors for young women to explore science and technology — not just as students, but as future leaders. When we invest in their potential, we invest in a more equitable, innovative, and prosperous society."
This milestone not only celebrates the opening of a world-class facility but also affirms the Health and Pharma Solutions Business Group’s dedication to advancing pharmaceutical innovation and building lasting partnerships that will shape the future of healthcare in Latin America.
Learn more about the Innovation Center here.
About Roquette
Roquette is a leading provider of plant-based ingredients, excipients and pharmaceutical solutions dedicated to enhancing the quality and convenience of essential products for consumers and patients worldwide.
Roquette employs more than 11,000 people globally, operating in more than 150 countries through more than 40 manufacturing sites and 20 R&D and innovation centers. The company achieved a turnover of €4.5 billion in 2024.
Harnessing natural resources like wheat, corn and cellulose, Roquette crafts high-performance ingredients and solutions used in everyday foods, oral medications, advanced biopharmaceuticals, and bio-based products.
Roquette is a family-owned company driven by a long-term vision and a constant commitment to innovation. For almost a century, Roquette has been empowering better living and building a sustainable future by offering the best of nature.
Discover more about Roquette here.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251016102423/en/
Contacts
Press Contacts:
Roquette Health & Pharma Business Group Communications:
Lisa Luke | Lisa.Luke@roquette.com
Barrett Dixon Bell:
Millie Clee, senior account executive | Millie.clee@bdb.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Stefanini Honored at ISG Women in Digital Awards EMEA as Natalia Chiritescu Wins Bronze Luminary for AI Leadership16.10.2025 18:23:00 EEST | Press release
Information Services Group (ISG) has honored Stefanini at the Women in Digital Awards in EMEA, celebrating Natalia Chiritescu. Chiritescu, Digital Solutions Center (DSC) Director for EMEA, NA, & APAC, was awarded “Bronze Luminary” in the AI Champion category recognizing AI adoption and enablement impact. The ISG Women in Digital Awards program, launched in the Americas in 2022, was expanded in 2023 to the Europe, Middle East and Africa (EMEA) and Asia Pacific regions, including India. In 2025, the global program had a total of 536 finalists and winners were announced on September. “The Women in Digital Awards aim to elevate and connect visionary women across the tech landscape. Natalia Chiritescu’s achievement is a testament to the program’s purpose: to foster collaboration, innovation, and diversity, empowering leaders to drive AI-enabled transformation worldwide,” said Kimberly Tobias, Partner and Leader of ISG Women in Digital. “Being named an AI Champion by ISG is an honor I share
CyberArk Named a Leader in the 2025 Gartner® Magic Quadrant™ for Privileged Access Management16.10.2025 18:06:00 EEST | Press release
CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced it has been named a Leader in the 2025 Gartner® Magic Quadrant™ for Privileged Access Management1. Recognized as a Leader for the seventh consecutive time, CyberArk is positioned furthest in Completeness of Vision which, from the company's standpoint, reflects CyberArk's commitment to defining the future of privilege access management (PAM), where every identity is protected with flexible as-needed access, smart AI-driven privilege controls, and unified security across both cloud and on-premises systems. The report evaluates tools that manage privileged access for both humans and machines. The CyberArk Identity Security Platform enables organizations to secure all identities – human, machine and AI – with the right level of privilege controls from a single, unified platform. As part of this platform, CyberArk's Privileged Access Management solutions help security teams secure privileged credentials, secret
HistoSonics Announces Oversubscribed $250 Million Growth Financing16.10.2025 17:00:00 EEST | Press release
HistoSonics, Inc., the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the closing of an oversubscribed $250 million financing led by its new ownership group and included additional investors Thiel Bio and Founders Fund, among others. The financing will support the ongoing commercial expansion of HistoSonics’ Edison System into new global markets, accelerate new clinical indications throughout the body, and strengthen operational capacity for the next phase of growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016119331/en/ HistoSonics Non-Invasive Edison Histotripsy System Image credit: HistoSonics This funding follows the recent $2.25 billion majority stake acquisition of HistoSonics by a consortium of international technology and life science investors, including K5 Global, Bezos Expeditions, and Wellington Management, who all participated in the new round that po
The Estée Lauder Companies’ Oevel Manufacturing & Fulfillment Campus Celebrates 60 Years of Excellence and Innovation16.10.2025 16:01:00 EEST | Press release
The Estée Lauder Companies Inc. (NYSE:EL), today celebrated the sixtieth anniversary of its Manufacturing & Fulfillment Campus in Oevel, Belgium. Since its opening in 1965, the Oevel Campus has developed into a state-of-the-art manufacturing, fulfillment and biotech hub. Today the campus serves as a cornerstone of the company’s global value chain and is one of its largest manufacturing facilities by volume, annually producing over 100 million prestige beauty products, which are then shipped to more than 100 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016330616/en/ The Estée Lauder Companies celebrates 60th anniversary of its Manufacturing & Fulfillment Campus in Oevel, Belgium “Nearly sixty years ago, my grandparents, Estée and Joseph Lauder, laid the cornerstone of our first facility here in Oevel, establishing what would become a vital part of our global operations,” said William P. Lauder, Chair, Board of
Global Study Finds Most SAP Customers Favor Multi-Vendor Composable ERP for Faster Innovation, Including AI16.10.2025 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced research findings around the SAP roadmap. In an in-depth study and interactive interview of 455 IT and business leaders, SAP customers voiced concerns over the push toward subscription-based S/4HANA and shared strategies business leaders are adopting to drive innovation and growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016604661/en/ Global Study Finds Most SAP Customers Favor Multi-Vendor Composable ERP for Faster Innovation, Including AI Data revealed that while nearly all SAP customers surveyed are finding it difficult to make a positive ROI case for S/4HANA, many are instead choosing a multi-vendor composable ERP strategy to integrate best-in-class solutions and emerging techn
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom